164 related articles for article (PubMed ID: 20516533)
41. Intra-abdominal fat is a major determinant of the National Cholesterol Education Program Adult Treatment Panel III criteria for the metabolic syndrome.
Carr DB; Utzschneider KM; Hull RL; Kodama K; Retzlaff BM; Brunzell JD; Shofer JB; Fish BE; Knopp RH; Kahn SE
Diabetes; 2004 Aug; 53(8):2087-94. PubMed ID: 15277390
[TBL] [Abstract][Full Text] [Related]
42. Ultrasound evaluation of visceral fat and metabolic risk factors during early pregnancy.
Bartha JL; Marín-Segura P; González-González NL; Wagner F; Aguilar-Diosdado M; Hervias-Vivancos B
Obesity (Silver Spring); 2007 Sep; 15(9):2233-9. PubMed ID: 17890491
[TBL] [Abstract][Full Text] [Related]
43. The relative contributions of the abdominal visceral and subcutaneous fat depots to cardiometabolic risk in youth.
Kelly AS; Dengel DR; Hodges J; Zhang L; Moran A; Chow L; Sinaiko AR; Steinberger J
Clin Obes; 2014 Apr; 4(2):101-7. PubMed ID: 24683420
[TBL] [Abstract][Full Text] [Related]
44. Abdominal visceral and subcutaneous fat increase, insulin resistance and hyperlipidemia in testicular cancer patients treated with cisplatin-based chemotherapy.
Willemse PM; van der Meer RW; Burggraaf J; van Elderen SG; de Kam ML; de Roos A; Lamb HJ; Osanto S
Acta Oncol; 2014 Mar; 53(3):351-60. PubMed ID: 23957624
[TBL] [Abstract][Full Text] [Related]
45. Change in CT-measured abdominal subcutaneous and visceral but not thigh fat areas predict future insulin sensitivity.
Liu AW; Song SO; Hayashi T; Sato KK; Kahn SE; Leonetti DL; Fujimoto WY; Boyko EJ
Diabetes Res Clin Pract; 2019 Aug; 154():17-26. PubMed ID: 31228493
[TBL] [Abstract][Full Text] [Related]
46. Abdominal subcutaneous and visceral fat thickness in newborns: correlation with anthropometric and metabolic profile.
Ferreira AP; da Silva Junior JR; Figueiroa JN; Alves JG
J Perinatol; 2014 Dec; 34(12):932-5. PubMed ID: 24901453
[TBL] [Abstract][Full Text] [Related]
47. The Relationship between Abdominal Fat Phenotypes and Insulin Resistance in Non-Obese Individuals after Acute Pancreatitis.
Ko J; Skudder-Hill L; Cho J; Bharmal SH; Petrov MS
Nutrients; 2020 Sep; 12(9):. PubMed ID: 32967240
[TBL] [Abstract][Full Text] [Related]
48. The combination of insulin resistance and visceral adipose tissue estimation improves the performance of metabolic syndrome as a predictor of type 2 diabetes.
Antonio-Villa NE; Bello-Chavolla OY; Vargas-Vázquez A; Mehta R; Aguilar-Salinas CA;
Diabet Med; 2020 Jul; 37(7):1192-1201. PubMed ID: 32061103
[TBL] [Abstract][Full Text] [Related]
49. Relationships between Composition of Major Fatty Acids and Fat Distribution and Insulin Resistance in Japanese.
Fujii C; Kawai T; Azuma K; Oguma Y; Katsukawa F; Hirose H; Tanaka K; Meguro S; Matsumoto H; Itoh H
J Diabetes Res; 2017; 2017():1567467. PubMed ID: 28540308
[No Abstract] [Full Text] [Related]
50. Does measurement site for visceral and abdominal subcutaneous adipose tissue alter associations with the metabolic syndrome?
Kuk JL; Church TS; Blair SN; Ross R
Diabetes Care; 2006 Mar; 29(3):679-84. PubMed ID: 16505526
[TBL] [Abstract][Full Text] [Related]
51. MRI total sagittal abdominal diameter as a predictor of metabolic syndrome compared to visceral fat at L4-L5 level.
Valsamakis G; Jones A; Chetty R; McTernan PG; Boutsiadis A; Barnett AH; Banerjee AK; Kumar S
Curr Med Res Opin; 2008 Jul; 24(7):1853-60. PubMed ID: 18507894
[TBL] [Abstract][Full Text] [Related]
52. Should visceral fat be reduced to increase longevity?
Finelli C; Sommella L; Gioia S; La Sala N; Tarantino G
Ageing Res Rev; 2013 Sep; 12(4):996-1004. PubMed ID: 23764746
[TBL] [Abstract][Full Text] [Related]
53. Sonographic subcutaneous and visceral fat indices represent the distribution of body fat volume.
Koda M; Senda M; Kamba M; Kimura K; Murawaki Y
Abdom Imaging; 2007; 32(3):387-92. PubMed ID: 16947071
[TBL] [Abstract][Full Text] [Related]
54. Association of Sonographically Assessed Visceral and Subcutaneous Abdominal Fat with Insulin Resistance in Prediabetes.
Fatima J; Gupta N; Karoli R; Chandra A; Jagirdaar S; Arora R; Pandey N
J Assoc Physicians India; 2019 Apr; 67(4):68-70. PubMed ID: 31299843
[TBL] [Abstract][Full Text] [Related]
55. Subcutaneous abdominal adipose tissue is associated with an index of insulin sensitivity/resistance.
Niijima K; Shimoda Y; Saito T; Yamada E; Niijima Y; Okada S; Yamada M
Adipocyte; 2016; 5(4):375-377. PubMed ID: 27994951
[TBL] [Abstract][Full Text] [Related]
56. Intra-abdominal and subcutaneous abdominal fat as predictors of cardiometabolic risk in a sample of Mexican children.
González-Álvarez C; Ramos-Ibáñez N; Azprioz-Leehan J; Ortiz-Hernández L
Eur J Clin Nutr; 2017 Sep; 71(9):1068-1073. PubMed ID: 28378850
[TBL] [Abstract][Full Text] [Related]
57. Family history of type 2 diabetes, abdominal adipocyte size and markers of the metabolic syndrome.
Anthanont P; Ramos P; Jensen MD; Hames KC
Int J Obes (Lond); 2017 Nov; 41(11):1621-1626. PubMed ID: 28736442
[TBL] [Abstract][Full Text] [Related]
58. Ceramide changes in abdominal subcutaneous and visceral adipose tissue among diabetic and nondiabetic patients.
Brusatori M; Wood MH; Tucker SC; Maddipati KR; Koya SK; Auner GW; Honn KV; Seyoum B
J Diabetes; 2022 Apr; 14(4):271-281. PubMed ID: 35470585
[TBL] [Abstract][Full Text] [Related]
59. The visceral and subcutaneous fat changes in type 1 diabetes: a pilot study.
Jacob AN; Adams-Huet B; Raskin P
Diabetes Obes Metab; 2006 Sep; 8(5):524-30. PubMed ID: 16918587
[TBL] [Abstract][Full Text] [Related]
60. Quantification of the visceral and subcutaneous fat by computed tomography: interobserver correlation of a single slice technique.
Sottier D; Petit JM; Guiu S; Hamza S; Benhamiche H; Hillon P; Cercueil JP; Krausé D; Guiu B
Diagn Interv Imaging; 2013 Sep; 94(9):879-84. PubMed ID: 23725783
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
